Forecast for food allergen immunotherapy: partly desensitized or a chance of cure?
Narisety
Satya D
SD
Wood
Robert A
RA
D000485:Allergens / Q000378:metabolism / Q000627:therapeutic use*; D000707:Anaphylaxis / Q000209:etiology / Q000517:prevention & control; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D003131:Combined Modality Therapy; D003888:Desensitization, Immunologic / Q000009:adverse effects / Q000639:trends*; D004035:Diet Therapy; D004333:Drug Administration Routes; D054796:Drug Dosage Calculations; D004358:Drug Therapy; D005512:Food Hypersensitivity / Q000276:immunology / Q000628:therapy*; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007108:Immune Tolerance; D011537:Pruritus / Q000209:etiology / Q000517:prevention & control; D000069283:Rituximab
D000485:Allergens; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab